Well I'm not totally oblivious to how it will behave considering phase 3 results should be ready Q2 2017. The only thing that will move it substantially is if they license some product and what are the odds of that before phase 3 is reached?
I have changed my sentiment to sell, but it is a 'great' stock for the future.
Good luck all, I hope it explodes this year, then I will look really like a fried fish.
Ann: Outcomes of DMX-200 pre-IND meeting with the FDA-DXB.AX, page-39
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.005(1.08%) |
Mkt cap ! $258.6M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 49.0¢ | 46.5¢ | $1.370M | 2.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 39142 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 40922 | 6 |
View Market Depth
| Last trade - 14.23pm 29/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |